openPR Logo
Press release

Liquid Biopsy Market Demands with Major Eminent Vendors: Personal Genome Diagnostics, TrovaGene, Guardant Health, Raindance Technologies, Adaptive Biotechnologies, Qiagen, Cynvenio Biosystems Inc, Biocept and NeoGenomics

09-17-2018 09:10 AM CET | Health & Medicine

Press release from: Crystal Market Research - Healthcare

Liquid Biopsy Market

Liquid Biopsy Market

Crystal Market Research has announced the addition of the "Liquid Biopsy Market Growth, Trends and Forecast, 2018-2025" report to their offering.

Liquid Biopsy - Competitive Insights:

The leading players in the market are Personal Genome Diagnostics, TrovaGene, Guardant Health, Raindance Technologies, Adaptive Biotechnologies, Qiagen, Cynvenio Biosystems Inc, Biocept and NeoGenomics. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

Access sample copy of this report: https://www.crystalmarketresearch.com/report-sample/HC081243 .

Liquid Biopsy - Industry Outlook and Trend Analysis:

The Liquid Biopsy is expected to gain considerable market share by 2025, while registering itself at a significant compound annual growth rate (CAGR) during the forecast period. Liquid biopsy is a rapidly emerging alternative for customary tumor biopsies, created out of the requirement to gain the most amounts of molecular data regarding cancer with minimal surgical invasion. With quick improvements in NGS technology, liquid biopsies are assessed to take prime position with regards to cancer related investigation and probe. Besides, with foreseen positive outcomes from various clinical trials for the advancement of these tests and resulting bigger scaled clinical trials exhibiting viability, it is likely that the testing procedure will serve a more extensive base of patient in atomic checking settings.

Liquid Biopsy - Application Outlook and Trend Analysis:

The advent of complete commercialization of liquid biopsies is anticipated to be significantly problematic. Three major applications of liquid biopsy can be therapy selection for other metastatic cancers, therapy selection tool for metastatic breast cancers, and molecular health monitoring. With the rising frequency of metastatic cancer over the globe, the therapy selection tool for metastatic breast cancers section is anticipated to hold an extensive share in the market all through the estimate time frame.

Liquid Biopsy - Sample Type Outlook and Trend Analysis:

Because of the various previous applications and techniques for purification, blood sampling is the most commonly used example for liquid biopsy studies and product improvements. Circulating tumor cells, cell-free DNA and exosomes and in addition microvesicles can be recognized in blood test. This brings about higher rate of adoption of liquid biopsy through blood testing. The next generation sequencing (NGS) technology is used in this for identification of numerous transformations in various genes.

Liquid Biopsy - Biomaker Type Outlook and Trend Analysis:

There are around 8-10 fluid biopsy tests on the basis of CTCs and ctDNA that are as of now commercialized. Moreover, more than 30 tests in view of each of the three of these biomarkers are in clinical improvement by some major market players. Commercialization of these tests in the offing is evaluated to profit the development of the general market.

Liquid Biopsy - Market Classification -

Liquid Biopsy Market, By Application, Estimates and Forecast, 2014-2025 ($Million)

Therapy Selection for Metastatic Breast Cancer (MBS)
Molecular Health Monitoring
Therapy Selection for Other Metastatic Cancer

Liquid Biopsy Market, By Sample Type, Estimates and Forecast, 2014-2025 ($Million)

Blood Sample-based
Urine Sample-based
Other Bio Fluids

Liquid Biopsy Market, By Biomaker Type, Estimates and Forecast, 2014-2025 ($Million)

Circulating Tumor Cells (CTC)
Exosomes
Circulating Tumor DNA (ctDNA)

In order to browse complete report with TOC: https://www.crystalmarketresearch.com/report/liquid-biopsy-market .

Liquid Biopsy Market, By Technology, Estimates and Forecast, 2014-2025 ($Million)

Single Gene Analysis (PCR Microarrays)
Multi-gene-parallel Analysis

Liquid Biopsy - Technology Outlook and Trend Analysis:

Based on technology, single gene analysis and multi gene analysis are the two main techniques used. PCR-based sequencing is used for analysis of changes in disease specific genes though analysis of numerous diseases all the while can be completed by using the NGS multiplex testing. PCR microarray and NGS technology are both viewed as vital for examination of previously mentioned biomarkers to perform any liquid biopsy analysis.

Liquid Biopsy - By Region:

North America - U.S, Canada, Mexico

Europe - Germany, France, UK, Italy, Spain, Rest of Europe

Asia-Pacific - Japan, China, Australia, India, South Korea, Rest of Asia Pacific

Rest of the World - Brazil, South Africa, Saudi Arabia, United Arab Emirates, Others

Liquid Biopsy - Regional Outlook and Trend Analysis:

North America was at the forefront of the market in 2016, trailed by Europe. The development of the area can be credited to recent regulatory approvals by CE for business application of these liquid biopsy tests. Nonetheless, Asia Pacific is probably going to enroll exceptional CAGR amid the gauge time frame as governments and organizations are endeavoring to continue developing growth predominance rates in the area under control. Japan, India, and China are the major contributing nations to the area's development.

Liquid Biopsy - List of Tables and Figures:

Figure United States Liquid Biopsy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Liquid Biopsy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Liquid Biopsy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Liquid Biopsy Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Liquid Biopsy Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Liquid Biopsy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Liquid Biopsy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Liquid Biopsy Revenue (Million USD) and Growth Rate (2014-2025)
...

Get more information of this report: https://www.crystalmarketresearch.com/send-an-enquiry/HC081243 .

Reason to Buy -

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the Liquid Biopsy market, thereby allowing players to develop effective long term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Continued…

About Crystal Market Research:

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customised research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liquid Biopsy Market Demands with Major Eminent Vendors: Personal Genome Diagnostics, TrovaGene, Guardant Health, Raindance Technologies, Adaptive Biotechnologies, Qiagen, Cynvenio Biosystems Inc, Biocept and NeoGenomics here

News-ID: 1241267 • Views:

More Releases from Crystal Market Research - Healthcare

Viral Vector And Plasmid Dna Manufacturing Market Outlook 2019 | Business Development | Research Report 2025
Viral Vector And Plasmid Dna Manufacturing Market Outlook 2019 | Business Develo …
Crystal Market Research Present Advance research on - Viral Vector And Plasmid Dna Manufacturing Market, approximates that the Viral Vector And Plasmid Dna Manufacturing Industry size is anticipated to flourish at a significant CAGR in the future. The Viral Vector and Plasmid DNA Manufacturing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Viral vectors and plasmid DNA manufacturing usually incorporates
Medical Digital Imaging Systems Market | Research Report 2019-2025 | Major Companies, Shimadzu, Koninklijke Philips N.V, Hitachi, GE Healthcare
Medical Digital Imaging Systems Market | Research Report 2019-2025 | Major Compa …
Crystal Market Research Present Advance research on "Medical Digital Imaging Systems Market", approximates that the Medical Digital Imaging Systems Industry size is anticipated to flourish at a significant CAGR in the future. The Medical Imaging is the process and technique of making the visual portrayals of the inside of the body for the purpose of medical intervention and clinical analysis, just as visual portrayal of the functioning of certain tissues (physiology)
Medical Device Complaint Management Market | Research Report 2019-2025 | Major Companies, MasterControl, IQVIA, Biovia, Sparta Systems
Medical Device Complaint Management Market | Research Report 2019-2025 | Major C …
Crystal Market Research Present Advance research on "Medical Device Complaint Management Market", approximates that the Medical Device Complaint Management Industry size is anticipated to flourish at a significant CAGR in the future. The manufacturers of medical gadget must keep record and also track the complaints of customer as per the Quality System Regulation (QSR) characterized in the 21 CFR Part 820. Furthermore, the FDA Part 803 guidelines need the firms
Veterinary Molecular Diagnostics Market | Research Report 2019-2025 | Major Companies, HealthGene Corporation, Thermo Fisher Scientific Inc, Bioneer, IDEXX Laboratories Inc
Veterinary Molecular Diagnostics Market | Research Report 2019-2025 | Major Comp …
The Universal Veterinary Molecular Diagnostics Market is anticipated to observe supported development over the foreseen period. The major development factor for the growth of Veterinary Molecular Diagnostics is the positive development in the beverage sector. Moreover, expanding canned food preference and increment in extra cash of the customers is the primary factors which are driving the market. Moreover, high recovery and recycling rate of the metal cans is anticipated to

All 5 Releases


More Releases for Bio

Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the
Global Bioplastics (Bio-plastics,Bio plastics) Market 2018 - Braskem, BASF
Apex Market Reports, recently published a detailed market research study focused on the “Bioplastics (Bio-plastics,Bio plastics) Market” across the global, regional and country level. The report provides 360° analysis of “Bioplastics (Bio-plastics,Bio plastics) Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Bioplastics
Worldwide Bio-Electronics Market 2025 – Global Analysis and Forecasts by Type …
Bio-Electronics is defined as the electronic devices used for bio-medical purposes, and helps in creating and evaluating the new technologies for better understanding of biological systems. The increasing demand of bio-electronics to meet the overwhelming need in healthcare industry will boost the bio-electronics market in forecast period. Furthermore, the growth in research of implantable devices for developing robust and reliable implantable medical devices will increase the demand of bio-electronics in
Bio Electronics and Bio Sensors Market Forecasts, 2017-2025
Description: The global bio electronic market is valued USD $15 billion in 2016 and is expected to grow at a CAGR of 11.6% during the forecast period 2017-2025. The market is driven by various factors such as rapid advancement in semiconductor technology, high demand in implantable medical devices, increasing prevalence of neural and cardiac diseases among others. The emerging healthcare technologies such as lab on chip, ambulatory surgical centres, and personalized devices are